Widely regarded as one of the most influential scientists of our time, Stephen Hawking was diagnosed with amyotrophic lateral sclerosis (ALS) at just 23. As the disease progressed, he became completely wheelchair-bound and eventually lost the ability to speak. Yet, despite profound physical limitations, Hawking reshaped humanity’s understanding of the universe and authored A Brief History of Time, one of the best-selling science books.
Hawking relied on assistive technologies to communicate—initially through subtle muscle movements in his cheek and later through sophisticated computer-based systems that converted signals into speech. These tools enabled him to lecture, write and co-author more than 20 books, reaching millions of people across the globe.
However, brain–computer interfaces (BCIs) were not sufficiently advanced during Hawking’s lifetime to fully restore natural communication. What technology achieved partially for Hawking, the next generation of BCIs may accomplish seamlessly for millions of people living with paralysis or neurodegenerative diseases.
Imagine a future where a person who cannot speak or move can send messages, operate a computer or control a wheelchair using only their thoughts. This is the promise of brain–computer interfaces—a rapidly advancing technology that directly connects the human brain to machines.
BCIs work by detecting tiny electrical signals generated by the brain and translating them into digital commands. While scientists have studied these signals for over a century, recent breakthroughs in artificial intelligence have dramatically accelerated progress. Today, two main approaches exist: invasive systems, which require brain surgery but offer high precision, and non-invasive systems, which use wearable devices placed on the scalp. Non-invasive BCIs are safer, more affordable, and better suited for large-scale use—particularly in countries like India.
Tiny brain–computer chips are already beginning to transform medicine. One notable success is Science Corp.’s Prima retinal implant, which has helped people with age-related macular degeneration regain the ability to read. Other companies are racing to restore lost functions: Neuralink has implanted chips enabling people with paralysis to type and control cursors using thought alone; Paradromics is developing high-speed interfaces for individuals with ALS or spinal cord injury; Blackrock Neurotech has helped paralysed patients communicate and control devices; and Synchron has pioneered systems implanted through blood vessels, avoiding open-brain surgery.
For India, the implications are far-reaching. BCIs could revolutionise rehabilitation for stroke survivors, people with spinal cord injuries, and those with severe disabilities. Beyond health care, they could reshape education, gaming, mental wellness and skill training—domains where India’s young, technology-driven population could lead global innovation.
Significant challenges remain. Brain signals are delicate, devices must become more comfortable and affordable, and robust safeguards are essential to protect privacy and mental autonomy. Ethical frameworks must evolve alongside technical progress.
Looking ahead, researchers envision BCIs not only restoring lost abilities but also enabling direct interaction with artificial intelligence. As these technologies advance, they raise powerful possibilities—as well as important questions about safety, equity, and responsible use.
With India’s strengths in engineering, artificial intelligence, and health care innovation, brain-computer interfaces represent not just a technological breakthrough, but an opportunity to shape a more inclusive, human-centred future.
Shyla Jovitha Abraham, is a health and wellness writer, based in Cleveland, and Dr Jame Abraham, is chairman, department of hematology/medical oncology and professor of medicine at Cleveland Clinic. The views expressed are his own and do not represent the views of Cleveland Clinic.